Skip to main content
Indivior PLC logo

Indivior PLC — Investor Relations & Filings

Ticker · INDV ISIN · GB00BN4HT335 LEI · 213800V3NCQTY7IED471 IL Manufacturing
Open in API
Filings indexed 1,983 across all filing types
Latest filing 2024-07-30 Regulatory Filings
Country GB United Kingdom
Listing IL INDV

About Indivior PLC

https://www.indivior.com/en

Indivior PLC is a global pharmaceutical company that develops, manufactures, and sells medicines to treat substance use disorders (SUD) and serious mental illnesses. The company's primary focus is on pioneering treatments for opioid use disorder (OUD), with a portfolio centered on buprenorphine-based prescription pharmaceuticals. Through its research and development efforts, Indivior aims to address the complex challenges of addiction and behavioral health by providing innovative, life-transforming therapies for patients worldwide.

Recent filings

Filing Released Lang Actions
TRANSACTION IN OWN SHARES
Regulatory Filings
2024-07-30 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is a formal notification published via RNS (Regulatory News Service) detailing a transaction by a Person Discharging Managerial Responsibilities (PDMR), specifically a Non-Executive Director, acquiring company shares. This directly matches the definition of a Director's Dealing report. The presence of 'RNS Number', 'NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES', and the structured table detailing the purchase aligns perfectly with the 'DIRS' (Director's Dealing) category. Although it is distributed via RNS, the specific content dictates the classification over the general 'RNS' fallback.
2024-07-30 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is explicitly titled 'NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM'. It details the purchase of Ordinary Shares by a Non-Executive Director (Juliet Thompson) and a closely associated person. This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). The RNS Number and reference to the London Stock Exchange confirm it is a regulatory disclosure, but the specific content points to 'DIRS'.
2024-07-30 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states it is a 'SHARE REPURCHASE PROGRAM WEEKLY REPORT' from Indivior PLC. It details the number of ordinary shares purchased for cancellation during a specific weekly period (July 22 to July 26, 2024) as part of a $100m Share Repurchase Program. This activity directly corresponds to the definition of 'Transaction in Own Shares' (share repurchase). The presence of the RNS Number and the footer mentioning RNS confirms it is a regulatory announcement, but the core content is the transaction details, making 'POS' the most specific classification.
2024-07-30 English
DIRECTOR/PDMR SHAREHOLDING
Regulatory Filings
2024-07-29 English
DIRECTOR/PDMR SHAREHOLDING
Regulatory Filings
2024-07-29 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.